C1q potentiates DR5 agonist activity by a mixture of two DR5-specific HexaBody® molecules. (October 2018) - Beurskens, Frank; Overdijk, Marije; Strumane, Kristin; Buijsse, Antonio Ortiz; Vermot-Desroches, Claudine; Kroes, Thessa; de Jong, Bart; Hoevenaars, Naomi; de Jong, Rob; Lingnau, Andreas; Parren, Paul; Schuurman, Janine; et al.